Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duveau

Showing results (231-240 of 248) with videos related to

Pageof 25
Sort By:
The American Journal of Gastroenterology|August 28, 2025
Sub-cutaneous infliximab for perianal Crohn's disease: the BioLap-Rem multicentre study from the GETAIDM André, J Kirchgesner, D Laharie, et al.
Gut|November 25, 2024
Top-down infliximab plus azathioprine versus azathioprine alone in patients with acute severe ulcerative colitis responsive to intravenous steroids: a parallel, open-label randomised controlled trial, the ACTIVE trialAurelien Amiot, Philippe Seksik, Antoine Meyer, et al.
Transplantation|February 17, 2005
Comparison of low and high initial tacrolimus dosing in primary heart transplant recipients: a prospective European multicenter studyBruno K Podesser, Mauro Rinaldi, Nizar A Yona, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 18, 2015
Donepezil decreases annual rate of hippocampal atrophy in suspected prodromal Alzheimer's diseaseBruno Dubois, Marie Chupin, Harald Hampel, et al.
Alimentary Pharmacology & Therapeutics|December 19, 2022
Effectiveness and safety of risankizumab induction therapy for 100 patients with Crohn's disease: A GETAID multicentre cohort studyMathurin Fumery, Antoine Defrance, Xavier Roblin, et al.
Transplantation|January 30, 2025
Should We Transplant Candidates With a Positive SARS-CoV-2 RT-PCR Test?Ilies Benotmane, Nathan Kasriel, Christophe Masset, et al.
Kidney International|August 28, 2020
An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplantsSophie Caillard, Dany Anglicheau, Marie Matignon, et al.
Journal of Crohn'S & Colitis|September 10, 2025
Subcutaneous vedolizumab dose intensification in inflammatory bowel disease patients: the OPTI-VEDO multicenter study from the GETAIDPauline Wils, Romain Altwegg, Anthony Buisson, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 10, 2024
Long-term Outcome of Risankizumab in Crohn's Disease: a Real-world GETAID StudyMathurin Fumery, Benedicte Caron, Xavier Hébuterne, et al.
Kidney International Reports|September 26, 2022
Absence of Mortality Differences Between the First and Second COVID-19 Waves in Kidney Transplant RecipientsBastien Berger, Marc Hazzan, Nassim Kamar, et al.
Pageof 25

Showing results (231-240 of 248) with videos related to

Sort By:
Pageof 25
The American Journal of Gastroenterology|August 28, 2025
Sub-cutaneous infliximab for perianal Crohn's disease: the BioLap-Rem multicentre study from the GETAIDM André, J Kirchgesner, D Laharie, et al.
Gut|November 25, 2024
Top-down infliximab plus azathioprine versus azathioprine alone in patients with acute severe ulcerative colitis responsive to intravenous steroids: a parallel, open-label randomised controlled trial, the ACTIVE trialAurelien Amiot, Philippe Seksik, Antoine Meyer, et al.
Transplantation|February 17, 2005
Comparison of low and high initial tacrolimus dosing in primary heart transplant recipients: a prospective European multicenter studyBruno K Podesser, Mauro Rinaldi, Nizar A Yona, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 18, 2015
Donepezil decreases annual rate of hippocampal atrophy in suspected prodromal Alzheimer's diseaseBruno Dubois, Marie Chupin, Harald Hampel, et al.
Alimentary Pharmacology & Therapeutics|December 19, 2022
Effectiveness and safety of risankizumab induction therapy for 100 patients with Crohn's disease: A GETAID multicentre cohort studyMathurin Fumery, Antoine Defrance, Xavier Roblin, et al.
Transplantation|January 30, 2025
Should We Transplant Candidates With a Positive SARS-CoV-2 RT-PCR Test?Ilies Benotmane, Nathan Kasriel, Christophe Masset, et al.
Kidney International|August 28, 2020
An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplantsSophie Caillard, Dany Anglicheau, Marie Matignon, et al.
Journal of Crohn'S & Colitis|September 10, 2025
Subcutaneous vedolizumab dose intensification in inflammatory bowel disease patients: the OPTI-VEDO multicenter study from the GETAIDPauline Wils, Romain Altwegg, Anthony Buisson, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 10, 2024
Long-term Outcome of Risankizumab in Crohn's Disease: a Real-world GETAID StudyMathurin Fumery, Benedicte Caron, Xavier Hébuterne, et al.
Kidney International Reports|September 26, 2022
Absence of Mortality Differences Between the First and Second COVID-19 Waves in Kidney Transplant RecipientsBastien Berger, Marc Hazzan, Nassim Kamar, et al.
Pageof 25